OnKure Therapeutics, Inc. (OKUR)
3.63
-0.16
(-4.22%)
USD |
NASDAQ |
Aug 31, 16:00
3.69
+0.06
(+1.65%)
After-Hours: 20:00
OnKure Therapeutics Cash from Operations (TTM) : -47.84M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -47.84M |
| March 31, 2026 | -50.76M |
| December 31, 2025 | -51.83M |
| September 30, 2025 | -61.33M |
| June 30, 2025 | -58.96M |
| March 31, 2025 | -52.15M |
| December 31, 2024 | -48.78M |
| September 30, 2024 | -18.38M |
| June 30, 2024 | -26.49M |
| March 31, 2024 | -36.13M |
| December 31, 2023 | -34.55M |
| September 30, 2023 | -59.54M |
| Date | Value |
|---|---|
| June 30, 2023 | -51.57M |
| March 31, 2023 | -47.41M |
| December 31, 2022 | -47.36M |
| September 30, 2022 | -41.77M |
| June 30, 2022 | -40.65M |
| March 31, 2022 | -38.39M |
| December 31, 2021 | -37.98M |
| September 30, 2021 | -33.37M |
| June 30, 2021 | -29.44M |
| March 31, 2021 | -22.68M |
| December 31, 2020 | -18.54M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Theriva Biologics, Inc. | -12.74M |
| Nkarta, Inc. | -92.76M |
| Unicycive Therapeutics, Inc. | -27.84M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |